Experimental Rice U. therapy could repair mutations that cause genetic diseases
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container drawn from a particular species of moth to deliver CRISPR/Cas9 payloads that modify genes in a specific tissue or organ with spatial control.
Because magnetic fields are simple to manipulate and, unlike light, pass easily through tissue, Bao and his colleagues want to use them to control the expression of viral payloads in target tissues by activating the virus that is otherwise inactivated in blood.
The research appears in Nature Biomedical Engineering.
In nature, CRISPR/Cas9 bolsters microbes’ immune systems by recording the DNA of invaders. That gives microbes the ability to recognize and attack returning invaders, but scientists have been racing to adapt CRISPR/Cas9 to repair mutations that cause genetic diseases and to manipulate DNA in laboratory experiments.
CRISPR/Cas9 has the potential to halt hereditary disease – if scientists can get the genome-editing machinery to the right cells inside the body. But roadblocks remain, especially in delivering the gene-editing payloads with high efficiency.
Bao said it will be necessary to edit cells in the body to treat many diseases. “But efficiently delivering genome-editing machinery into target tissue in the body with spatial control remains a major challenge,” Bao said. “Even if you inject the viral vector locally, it can leak to other tissues and organs, and that could be dangerous.”
The delivery vehicle developed by Bao’s group is based on a virus that infects Autographa californica, aka the alfalfa looper, a moth native to North America. The cylindrical baculovirus vector (BV), the payload-carrying part of the virus, is considered large at up to 60 nanometers in diameter and 200-300 nanometers in length. That’s big enough to transport more than 38,000 base pairs of DNA, which is enough to supply multiple gene-editing units to a target cell, Bao said.
He said the inspiration to combine BV and magnetic nanoparticles came from discussions with Rice postdoctoral researcher and co-lead author Haibao Zhu, who learned about the virus during a postdoctoral stint in Singapore but knew nothing about magnetic nanoparticles until he joined the Bao lab. The Rice team had previous experience using iron oxide nanoparticles and an applied magnetic field to open blood vessel walls just enough to let large-molecule drugs pass through.
“We really didn’t know if this would work for gene editing or not, but we thought, ‘worth a shot,’” Bao said.
The researchers use the magnetic nanoparticles to activate BV and deliver gene-editing payloads only where they’re needed. To do this, they take advantage of an immune-system protein called C3 that normally inactivates baculoviruses.
“If we combine BV with magnetic nanoparticles, we can overcome this deactivation by applying the magnetic field,” Bao said. “The beauty is that when we deliver it, gene editing occurs only at the tissue, or the part of the tissue, where we apply the magnetic field.”
Application of the magnetic field allows BV transduction, the payload-delivery process that introduces gene-editing cargo into the target cell. The payload is also DNA, which encodes both a reporter gene and the CRISPR/Cas9 system.
In tests, the BV was loaded with green fluorescent proteins or firefly luciferase. Cells with the protein glowed brightly under a microscope, and experiments showed the magnets were highly effective at targeted delivery of BV cargoes in both cell cultures and lab animals.
Bao noted his and other labs are working on the delivery of CRISPR/Cas9 with adeno-associated viruses (AAV), but he said BV’s capacity for therapeutic cargo is roughly eight times larger. “However, it is necessary to make BV transductioninto target cells more efficient,” he said.
Learn more: Moths and magnets could save lives
The Latest on: Genetic diseases
via Google News
The Latest on: Genetic diseases
- Adoptees Have Slightly Higher Genetic Risk for Mental Illnesson February 2, 2020 at 7:30 am
Adopted children have an increased risk for depression, anxiety and other mental health disorders. Research has primarily attributed this to stressful early childhoods, but a new study finds that ...
- HMC & HUH showcase recent achievements at 3rd research conference on rare diseaseson February 1, 2020 at 4:00 pm
and Heidelberg University Hospital (HUH) presented the achievements of their collaboration at the third Doha–Heidelberg Research Conference on Rare Diseases. The event was held to mark the first ...
- New genetic screen for Huntington’s diseaseon January 30, 2020 at 11:15 am
Huntington’s disease is a genetic disease that is debilitating and progressive leading to severe brain damage and eventual death. In patients with this autosomal dominant disease, there is presence of ...
- Researchers improve animal welfare by discovering genetic mutations that cause diseaseon January 30, 2020 at 9:50 am
Humans and animals are made up of trillions of cells, and each cell contains DNA specific to that individual. Therefore, identifying DNA that causes genetic disorders gives researchers and clinicians ...
- Genetic screen offers new drug targets for Huntington's diseaseon January 30, 2020 at 8:01 am
Using a type of genetic screen that had previously been impossible in the mammalian brain, MIT neuroscientists have identified hundreds of genes that are necessary for neuron survival. They also used ...
- Germany Genetic Diseases, Cancer, Forensic & Paternity Molecular Diagnostic Testing, 2020 - ResearchAndMarkets.comon January 29, 2020 at 6:00 am
DUBLIN--(BUSINESS WIRE)--The "2020 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, ...
- Gene Therapy Industry Insights and Outlook to 2028 - Genetic Disorders, Cancer, Neurological Disorders, Cardiovascular Disorders, and Viral Infectionson January 28, 2020 at 11:15 am
/PRNewswire/ -- The "Gene Therapy - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
- New study of genes in Asian populations may help better understand, treat genetic diseaseson January 28, 2020 at 9:38 am
An ambitious new study of genes in Asian populations is filling in big gaps in our understanding of human genetics, shedding light on the history of human migration and ultimately aiming to improve ...
- Genetic Disorders Drug Market With Thriving CAGR in Forecast Period 2019 to 2026on January 27, 2020 at 10:17 pm
Ameco Research has announced the addition of the "Global Genetic Disorders Drug Market: Global Industry Size, Share, Trends and Forecast, 2019-2026″ report to their offering. The global Genetic ...
via Bing News